Cheng C, Shuman S
Molecular Biology Program, Sloan-Kettering Institute, New York, New York 10021, USA.
J Biol Chem. 1998 May 8;273(19):11589-95. doi: 10.1074/jbc.273.19.11589.
Eukaryotic type IB topoisomerases catalyze the cleavage and rejoining of DNA strands through a DNA-(3'-phosphotyrosyl)-enzyme intermediate. The 314-amino acid vaccinia topoisomerase is the smallest member of this family and is distinguished from its cellular counterparts by its specificity for cleavage at the target sequence 5'-CCCTT downward arrow. Here we show that Topo-(81-314), a truncated derivative that lacks the N-terminal domain, performs the same repertoire of reactions as the full-sized topoisomerase: relaxation of supercoiled DNA, site-specific DNA transesterification, and DNA strand transfer. Elimination of the N-terminal domain slows the rate of single-turnover DNA cleavage by 10(-3.6), but has little effect on the rate of single-turnover DNA religation. DNA relaxation and strand cleavage by Topo-(81-314) are inhibited by salt and magnesium; these effects are indicative of reduced affinity in noncovalent DNA binding. We report that identical properties are displayed by a full-length mutant protein, Topo(Y70A/Y72A), which lacks two tyrosine side chains within the N-terminal domain that contact the DNA target site in the major groove. We speculate that Topo-(81-314) is fully competent for transesterification chemistry, but is compromised with respect to a rate-limiting precleavage conformational step that is contingent on DNA contacts made by Tyr-70 and Tyr-72.
真核生物 I 型拓扑异构酶通过 DNA-(3'-磷酸酪氨酸)-酶中间体催化 DNA 链的切割和重新连接。314 个氨基酸的痘苗病毒拓扑异构酶是该家族中最小的成员,其与细胞内对应物的区别在于它对靶序列 5'-CCCTT 向下箭头处切割的特异性。在这里,我们表明 Topo-(81-314),一种缺少 N 端结构域的截短衍生物,与全长拓扑异构酶具有相同的反应类型:超螺旋 DNA 的松弛、位点特异性 DNA 转酯反应和 DNA 链转移。N 端结构域的缺失使单轮 DNA 切割速率减慢 10(-3.6),但对单轮 DNA 重新连接速率影响很小。Topo-(81-314)的 DNA 松弛和链切割受到盐和镁的抑制;这些效应表明非共价 DNA 结合中的亲和力降低。我们报告说,全长突变蛋白 Topo(Y70A/Y72A)也表现出相同的特性,该蛋白在 N 端结构域内缺少两个在大沟中与 DNA 靶位点接触的酪氨酸侧链。我们推测 Topo-(81-314)在转酯化学方面完全有能力,但在依赖于 Tyr-70 和 Tyr-72 与 DNA 接触的限速切割前构象步骤方面存在缺陷。